Premaitha Health (NIPT)

 

NIPT Share PerformanceMore

52 week high14.40 06/03/17
52 week low7.00 03/02/17
52 week change 0.32 (3.19%)
4 week volume7,742,686 02/04/17

Media for (NIPT)

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Holding(s) in Company

RNS Number: 4336B Premaitha Health PLC 03 April 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Premaitha Health plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acqu...

Second tranche of warrants issued to Thermo Fisher

RNS Number: 2363B Premaitha Health PLC 31 March 2017 Premaitha Health Plc ("Premaitha" or the "Company") Second tranche of warrants issued to Thermo Fisher Scientific Manchester, UK - 31 March 2017 - Premaitha Health PLC (AIM: NIPT), a leading international molecular diagnostics group focused on prenatal testing, announces that it has issued the second...

Hardman Research: Expanding global distribution

RNS Number: 7488Z Premaitha Health PLC 17 March 2017 Hardman Research: Expanding global distribution network Expanding global distribution network: Premaitha uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests. IONA uses complex statistical analyses to determine the likelihood that a fetus is carrying a disorder...

Premaitha to Attend International Medical Events

RNS Number: 1996Z Premaitha Health PLC 13 March 2017 Premaitha Health PLC (" Premaitha " or the "Company " ) Premaitha Raises Awareness of the IONA Test at Key International Medical Events Manchester, UK - 13 March 2017: Premaitha Health PLC ( AIM: NIPT ) , a leading international molecular diagnostics group focused on prenatal testing, will be atten...

Completion of Yourgene Acquisition

RNS Number: 3601Y Premaitha Health PLC 02 March 2017 Premaitha Health plc (" Premaitha " or the "Company " ) Directorate Change, Completion of Yourgene Acquisition and Admission of Shares Manchester, UK - 2 March 2017: Premaitha Health plc (AIM: NIPT), a leading international molecular diagnostics group, announces that following the admission of 76...

Completion of Acquisition

RNS Number: 8594X Premaitha Health PLC 27 February 2017 Premaitha Health PLC (" Premaitha " or the "Company " or the "Group") Completion of Yourgene Acquisition, Issue of Shares and Director Appointments Manchester, UK - 27 February 2017: Premaitha Health PLC ( AIM: NIPT ) , a leading international molecular diagnostics group focused on prenatal ...

Holding(s) in Company

RNS Number: 5464X Premaitha Health PLC 22 February 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii PREMAITHA HEALTH PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting r...

Middle East Business Update

RNS Number: 2435X Premaitha Health PLC 20 February 2017 Premaitha Health PLC (" Premaitha " or the "Company " ) Middle East Business Update Manchester, UK - 20 February 2017: Premaitha Health PLC ( AIM: NIPT ) , developer of a leading CE - marked non - invasive prenatal screening system, is pleased to announce significant commercial progress in the ...

Fundamental DataMore

EPS-6
Dividend yield0 %

Equity Research (NIPT)

hardman & co
Premaitha Health PLC
17/03/2017
Premaitha uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests. IONA uses complex statistical analyses to determine the likelihood that a fetus is carrying...
hardman & co
Premaitha Health PLC
11/01/2017
Premaitha uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests. IONA uses complex statistical analyses to determine the likelihood that a fetus is carrying...
hardman & co
Premaitha Health PLC
20/04/2016
Premaitha uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests. IONA® uses complex statistical analysis to determine the likelihood that a fetus is carrying...

Latest discussion posts More

  • Final Tranche Of Warrants

    Premaitha Health Plc ("Premaitha" or the "Company") Second tranche of warrants issued to Thermo Fisher Scientific Manchester, UK - 31 March 2017 - Premaitha ...
    31-Mar-2017
    Disorder
  • Re: Tom Winnifrith

    NMS down to 20,000 shares though. A quote for 100,000 (Circa #11k.... So not a lot in scale of things) received a quote of 0.1112p Although we see daily trade volumes of in ...
    22-Mar-2017
    Disorder
  • Re: Tom Winnifrith

    Dropped 5% today .. now 10.75 to buy.
    21-Mar-2017
    Ripley94

Users' HoldingsMore

Users who hold Premaitha Health also hold..
LLOYDS GRP.20%
ROCKHOPPER19%
GULF KEYSTONE16%
ID:ISIN:VGG9828A119412%
SIRIUS MINERALS11%

Codes & Symbols

ISINGB00BN31ZD89
SymbolsNIPT, LSE:NIPT, NIPT.L, NIPT:LN, LON:NIPT, XLON:NIPT